Avesthagen Ltd on Monday said its ambitious Avestagenome project has entered a significant phase of sequencing 60 closely related human genomes.
The project is studying the genetic make-up and diseases that affect the small Parsi community, but are applicable to the entire population.
The sequencing, once completed, would provide a better understanding of the genes that cause cancer, metabolic diseases such as diabetes and neurological disorders among people, the company said on Monday.
“Through this project, Avesthagen intends to establish a direct link between genes, genetics and the disorders themselves,” it said.
The Bangalore-based biotechnology company has tied up with Genome Enterprise Ltd, a subsidiary of the UK-based DNA sequencing and bioinformatics company, The Genome Analysis Centre….READ MORE